Africa IVD Market to be Worth $1.78 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

REDDING, Calif., Jan. 30, 2023 /PRNewswire/ -- According to a new market research report titled, 'Africa In-vitro Diagnostics Market by Product & Services, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), Customer Type — Forecast to 2029,' published by Meticulous Research^®, the Africa IVD market is projected to reach $1.78 billion by 2029, at a CAGR of 4.8% from 2022 to 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5415

The Africa IVD market report covers various IVD tests based on technologies such as immunoassay, whole blood glucose monitoring, molecular diagnostics, point-of-care diagnostics, clinical chemistry, hematology, coagulation & hemostasis, critical care, and urinalysis. IVD test kits are generally used by hospital labs, private labs, government bodies, long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories to detect various diseases.

Africa IVD Market: Future Outlook

The Africa IVD market is segmented based on Product Category (Reagents, Assays, and Kits; Instruments; and Software & Services), Technology (Immunoassay, Whole Blood Glucose Monitoring, Point-of-Care Diagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology, Coagulation & Hemostasis, Critical Care, Urinalysis, and Other IVD Technologies), Application (Infectious Diseases, Oncology, Diabetes, Endocrinology, Cardiology, and Other Applications), Diagnostic Approach (Laboratory Testing, Point of Care Testing, and OTC/Self Testing), and Customer Type (Hospital Labs, Private Labs, Home Care/Self Testing, Government, and Other Customer Types), and Geography (South Africa, Egypt, Nigeria, Kenya, Algeria, Tanzania, Morocco, Tunisia, and the rest of Africa). The study also evaluates the country-level markets in Africa.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5415

Based on product category, the Africa IVD market is segmented into reagents, assays, and kits; instruments; and software & services. In 2022, the reagents, assays, and kits segment accounted for the largest share of the Africa IVD market. The burden of HIV, tuberculosis, malaria, diabetes, cardiovascular diseases, neglected tropical diseases (NTDs), and vaccine-preventable diseases, including hepatitis, is high in Africa. For instance, according to International Diabetes Federation (IDF) Diabetes Atlas, in 2021, 24.0 million people (aged 20–79 years) were living with diabetes in Africa. The number of people living with diabetes in Africa is expected to increase by 129% to reach 55 million by 2045 (source: IDF Diabetes Atlas 2021). Thus, the high prevalence of communicable and non-communicable diseases, coupled with the frequent use of reagents, assays, and kits, contribute to the high adoption of reagents, assays, and kits.

Based on technology, the Africa IVD market is segmented into immunoassay, whole blood glucose monitoring, molecular diagnostics, point-of-care diagnostics, clinical chemistry, hematology, coagulation & hemostasis, critical care diagnostics, urinalysis, and other technologies (microscopy, hybridization, and loop-mediated amplification). In 2022, the immunoassay segment accounted for the largest share of the Africa IVD market. The demand for immunoassays remains high in Africa as it is the preferred diagnostic platform for diagnosing HIV, malaria, dengue, and other diseases in the region. Furthermore, the outbreak of the COVID-19 pandemic created significant growth opportunities for the immunoassays market. For instance, in March 2021, Abbott Laboratories (U.S.) launched an easy-to-use, portable nasal-swab antigen rapid test. The test provides results in up to 15 minutes and aims to scale up COVID-19 testing in Nigeria.

Based on application, the Africa IVD market is segmented into infectious diseases, diabetes, oncology, cardiology, endocrinology, and other applications (nephrology, toxicology, gastroenterology, neonatal, genetic, and neurological disorders). In 2022, the oncology segment is slated to register the highest growth rate during the forecast period, followed by the infectious diseases and cardiology segments. The Global Cancer Observatory (Globocan 2020) reported 1,109,209 new cancer cases and 711,429 cancer-related deaths in Africa in 2020. Early cancer detection and access to effective anti-cancer treatment can result in higher rates of survival and a better quality of life. Thus, these factors drive the demand for IVD kits for cancer screening in Africa.

Quick Buy – Africa IVD MarketMarket Research Report: https://www.meticulousresearch.com/Checkout/24576471

Based on diagnostic approach, the Africa IVD market is segmented into laboratory testing, point-of-care testing, and OTC/self-testing. In 2022, the laboratory testing segment accounted for the largest share of the Africa IVD market. Furthermore, laboratory equipment/analyzers and software offer high sensitivity and specificity, and laboratory tests are highly accurate and reliable. In addition, laboratory equipment/analyzers can manage and process more samples than self-tests or POC. Thus, the large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy offered by laboratory testing.

Based on customer type, the Africa in vitro diagnostics market is segmented into government, hospital laboratories, private laboratories, home care/self-testing, and other customer types (long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories). In 2022, the home care/self-testing segment is slated to register the highest growth rate during the forecast period, followed by hospital laboratories and private laboratories. The growth of this segment is attributed to the increasing need to monitor and manage chronic diseases, the growing awareness about the use of home healthcare testing products, and the rising need to reduce waiting time for testing results & healthcare costs. Furthermore, the prevalence of chronic diseases such as diabetes, CVD, and cancer is increasing rapidly in Africa. With the increase in disease prevalence, the use of IVD products has also increased in in-home settings. The availability of advanced IVD products and the increasing awareness about disease monitoring among the urban population have resulted in the high adoption of IVD tests in the region. Additionally, the easy availability of low-cost urine test strips and pregnancy test kits also contributes to the growth of this segment.

Based on geography, South Africa accounted for the largest share of this market in 2022. South Africa's major market share is attributed to the high burden of diseases, the rise in the geriatric population, initiatives to promote diagnostic testing, and continuous efforts to develop healthcare infrastructure and promote awareness.

Key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/africa-ivd-market-5415

Scope of the Report:

Africa IVD Market, by Product Category

• Reagents, Assays, and Kits
• Instruments
• Software & Services

Africa IVD Market, by Technology

• Immunoassay
• Whole Blood Glucose Monitoring
• Point-of-Care Diagnostics
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Coagulation & Hemostasis
• Critical Care
• Urinalysis
• Other IVD Technologies

Note: Other technologies include microscopy, hybridization, and loop-mediated amplification.

Africa IVD Market, by Application

• Infectious Diseases
• Diabetes
• Oncology
• Endocrinology
• Cardiology
• Other Applications

Note: Other applications include nephrology, toxicology, gastroenterology, neonatal, genetic, and neurological disorders.

Africa IVD Market, by Diagnostic Approach

• Laboratory Testing
• Point-of-Care Testing
• OTC/Self-testing

Africa IVD Market, by Customer Type

• Hospital Labs
• Private Labs
• Home Care/Self Testing
• Government
• Other Customer Types

Note: Other customer types include long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.

Africa IVD Market, by Country

• South Africa
• Egypt
• Nigeria
• Kenya
• Algeria
• Tanzania
• Morocco
• Tunisia
• Rest of Africa

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5415

Related Reports:

In-vitro Diagnostics Market (IVD Market) by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories) – Forecast to 2027

https://www.meticulousresearch.com/product/ivd-market-4858

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) - Global Forecast to 2027

https://www.meticulousresearch.com/product/in-vitro-diagnostic-reagents-market-5110

IVD Contract Manufacturing Services Market by Type (Assay Development, Manufacturing), Category (Reagents, Systems), Technology (Immunoassay, Molecular Diagnostics, Clinical Chemistry, Hematology, Microbiology, Urinalysis) - Global Forecast to 2028

https://www.meticulousresearch.com/product/ivd-contract-manufacturing-services-market-5226

Indonesia In Vitro Diagnostics Market by Product (Kits, Instruments, Software), Technology (Immunoassay, Hematology, Coagulation, Diabetes, Molecular), Application (Infectious Diseases, Cardiology, Oncology), and End User (Hospital, Diagnostic Lab, Home Care) - Forecast to 2029

https://www.meticulousresearch.com/product/indonesia-in-vitro-diagnostics-market-5352

Latin America In Vitro Diagnostics Market by Product & Service, Technology (Immunoassay, Point of Care, Molecular Diagnostics), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), Customer Type — Forecast to 2029

https://www.meticulousresearch.com/product/latin-america-in-vitro-diagnostics-IVD-market-5105

Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes) - Global Forecast to 2027

https://www.meticulousresearch.com/product/influenza-diagnostics-market-5099

Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli, Tuberculosis, Pneumonia, Cancer)- Forecast to 2029

https://www.meticulousresearch.com/product/diagnostic-specialty-antibodies-market-5241

Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Glucose, Infectious Diseases, Pregnancy, Drugs of Abuse), End User (Hospitals, Diagnostic Labs, Home Care) - Global Forecast to 2029

https://www.meticulousresearch.com/product/rapid-diagnostics-market-5240

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com 
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/643/africa-ivd-market-2029

Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg